Encelle, a developer of patented products for use in advanced wound repair and orthopedic repair, says it has completed a second human clinical trial for a proposed treatment of diabetic foot ulcers.
“This novel approach to healing diabetic foot ulcerations demonstrated the potential to improve healing rates with excellent safety,” said Jason Hanft, a doctor based in South Miami FL. “A pivotal trial is necessary to fully explore this potential for an interesting new treatment for a difficult disease state.”
The recently completed study included 56 patients.
Results of the trial are to be presented at two upcoming meetings addressing wound care and healing.
Encelle: www.encelle.com
